 |
 |

Lack of Efficacy of Haemophilus b Polysaccharide Vaccine in Minnesota
Michael T. Osterholm, PhD, MPH;
Joan H. Rambeck, MS, RN;
Karen E. White, MPH;
Jean L. Jacobs, RN;
Lynne M. Pierson;
James D. Neaton, PhD;
Craig W. Hedberg, MS;
Kristine L. MacDonald, MD;
Dan M. Granoff, MD
JAMA. 1988;260(10):1423-1428.
Abstract
We evaluated the efficacy of Haemophilus b polysaccharide vaccine in children in Minnesota using a case-control study. The vaccine became available in Minnesota in August 1985. During the subsequent 28 months, 88 cases of invasive H influenzae type b disease were identified in children 24 to 71 months of age, the group targeted for vaccination. Of the 88 cases, 36 (41%) occurred in vaccinated children. Fifty-eight (33%) of 176 controls were vaccinated during a similar period. The vaccine's protective efficacy for children with any history of vaccination was -58% (95% confidence interval = -204% to 18%). The vaccine's protective efficacy for children who were most likely to be protected by vaccination was -55% (95% confidence interval = -238% to 29%). Our results indicate that vaccination with Haemophilus b polysaccharide vaccine had no effect in preventing H influenzae type b disease in Minnesota children.
(JAMA 1988;260:1423-1428)
Author Affiliations
From the Acute Disease Epidemiology Section, Minnesota Department of Health (Drs Osterholm and MacDonald, Mss Rambeck, White, and Pierson, and Mr Hedberg), and the Division of Biometry, School of Public Health, University of Minnesota (Dr Neaton), Minneapolis; and the Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine (Dr Granoff), and the Division of Infectious Diseases, Children's Hospital (Dr Granoff), St Louis.
Footnotes
Reprint requests to Acute Disease Epidemiology Section, Minnesota Department of Health, 717 Delaware St SE, PO Box 9441, Minneapolis, MN 55440 (Dr Osterholm).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the Polysaccharide Vaccine and a Decade after the Advent of Conjugates
Peltola
Clin. Microbiol. Rev. 2000;13:302-317.
ABSTRACT
| FULL TEXT
Eradication of Haemophilus influenzae Type b Disease in Southern California
Vadheim et al.
Arch Pediatr Adolesc Med 1994;148:51-56.
ABSTRACT
Declining Incidence of Haemophilus influenzae Type b Disease Since Introduction of Vaccination
Murphy et al.
JAMA 1993;269:246-248.
ABSTRACT
Haemophilus b Disease After Vaccination With Haemophilus b Polysaccharide or Conjugate Vaccine
Frasch et al.
Arch Pediatr Adolesc Med 1991;145:1379-1382.
ABSTRACT
Immunoglobulin Deficiency and Idiotype Expression in Children Developing Haemophilus influenzae Type b Disease After Vaccination With Conjugate Vaccine
Holmes et al.
JAMA 1991;266:1960-1965.
ABSTRACT
Dose-Related Immunogenicity of Haemophilus influenzae Type b Capsular Polysaccharide--Neisseria meningitidis Outer Membrane Protein Conjugate Vaccine
Wong et al.
Arch Pediatr Adolesc Med 1991;145:734-741.
ABSTRACT
Protective Efficacy of Haemophilus influenzae Type b Polysaccharide and Conjugate Vaccines in Children 18 Months of Age and Older
Greenberg et al.
JAMA 1991;265:987-992.
ABSTRACT
Protective Efficacy of Haemophilus influenzae Type b Polysaccharide-Diphtheria Toxoid-Conjugate Vaccine
Nelson and Granoff
Arch Pediatr Adolesc Med 1990;144:292-295.
ABSTRACT
Interannual Variation of the Incidence of Haemophilus influenzae Type b Meningitis
Sherry et al.
JAMA 1989;261:1924-1929.
ABSTRACT
Haemophilus b Polysaccharide Vaccine
Coles et al.
JAMA 1989;261:1152-1152.
ABSTRACT
Haemophilus b Polysaccharide Vaccine-Reply
Harrison and Broome
JAMA 1989;261:1153-1153.
ABSTRACT
CONFLICTING DATA ON EFFICACY OF HAEMOPHILUS B VACCINE
JWatch General 1988;1988:1-1.
FULL TEXT
The Protective Efficacy of Haemophilus b Polysaccharide Vaccine
Shapiro et al.
JAMA 1988;260:1419-1422.
ABSTRACT
Efficacy of Haemophilus b Polysaccharide Vaccine: An Enigma
Mortimer
JAMA 1988;260:1454-1455.
ABSTRACT
|